Unicancer provides support to expert groups responsible for addressing questions on therapeutic strategies and research.
Institut de Cancérologie de Lorraine
6 Avenue de Bourgogne CS30 519
54519 Vandœuvre-lès-Nancy Cedex
54519 Vandœuvre-lès-Nancy Cedex
Tél. : 04 67 61 31 00
Fax : 04 67 41 08 59
Note HAS (French High Authority of Health)
A
Certification of the centre
by HAS - French High Authority of Health
by HAS - French High Authority of Health
80/100
Satisfaction and feedback
of the patient Overall score
of hospitalized patients
of the patient Overall score
of hospitalized patients
80/100
Satisfaction and feedback
of the patient Overall score
of patients admitted for outpatient surgery
of the patient Overall score
of patients admitted for outpatient surgery
The ICL, Cancer centre (Centre de lutte contre le cancer – CLCC) and private health establishment (établissement de santé privé d’intérêt collectif – ESPIC), member of Unicancer, dedicates its entire medical and paramedical activity to the diagnosis and treatment of cancer. Recognised as promoting the public interest, it does not work within the private sector and charges no additional fees.
The centre treats more than 15,000 patients per year, providing both standard and highly specific care.
Created in 1924, the Centre is located on the plateau de Brabois, near Nancy regional university hospital, with which it makes up the Lorraine regional cancer centre. The ICL is a member of the NEON health network (Eastern France).
Certified as a clinical research centre, the centre is an important stakeholder in research and participates in numerous projects.
Highly involved in teaching oncology in Lorraine, the ICL dispenses more than 3,000 hours teaching per year, part of which is accredited as “Continuing Professional Development”.
It collects donations to finance its research, innovation or patient support projects. The Institut de Cancérologie de Lorraine features among the Top 200 in the American magazine Newsweek’s “World’s best hospitals 2021” inaugural ranking, according to the recommendations of more than 40,000 experts and validation by a global panel of renowned medical experts.
170
Number of beds and places
747
Number of employees
15,072
Number of patients treated every year
Types of cancer treated
Cancers digestifs
Cancers de l’appareil génital masculin
Cancers urologiques
Tumeurs du système nerveux central
Cancer du poumon
Autres tumeurs thoraciques
Cancers de la sphère ORL
Cancer de la thyroïde et parathyroïde
Cancer du sein
Cancers gynécologiques
Tumeurs cutanées
Cancers oculaires
Tumeurs ostéoarticulaires
Cancers pédiatriques, des adolescents et jeunes adultes radiothérapie
Tumeurs rares
Oncogénétique
Sarcome
Tumeurs de la surrénale
Tumeurs neuro-endocrines
Treatments
Chirurgie
Radiothérapie
Tomothérapie
Radio-chirurgie
Curiethérapie
Chimiothérapie
Transfusions
Immunothérapie
Thérapies ciblées
Hormonothérapie
Radiologie interventionnelle
Soins de support
Oncogériatrie
Training courses
L’organisme de formation de l’ICL dispense des programmes agréés DPC (Développement Professionnel Continu) et est certifié qualité QUALIOPI. La certification qualité a été délivrée au titre de la catégorie d’action suivante : actions de formation.
Formations professionnels de santé :
• sur demande, formations sur mesure sur tous les thèmes de la cancérologie,
• oncologie médicale
• chirurgie
• radiothérapie
• soins de support
• imagerie médicale
